NBY - NovaBay Pharmaceuticals, Inc.

...

Available for logged in users only.

The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.

• NovaBay Pharmaceuticals posts 64% rise in 2023 Avenova unit subscription-based sales
• NovaBay GAAP EPS of -$0.37 beats by $0.04, revenue of $3.27M misses by $0.27M
• NovaBay Q3 2023 Earnings Preview
• NovaBay stock soars 86% on optic allograft product deal
• NovaBay GAAP EPS of -$1.27 misses by $0.71, revenue of $4.61M beats by $0.94M
• NovaBay Q2 2023 Earnings Preview
• NovaBay GAAP EPS of -$0.85 beats by $0.06, revenue of $3.12M misses by $0.08M
• NovaBay Pharmaceuticals down 18% on $3M convertible notes financing
• NovaBay surges ~20% on launch of DERMAdoctor psoriasis cream on QVC
• NovaBay Q4 2022 Earnings Preview
• NovaBay Pharma gains 10% on launch of new oral supplement to comfort dry eyes
• NovaBay Pharma announces 1-for-35 reverse stock split
• NovaBay GAAP EPS of -$0.10, revenue of $3.83M
• NovaBay Q3 2022 Earnings Preview
• NovaBay Q3 2022 Earnings Preview
• NovaBay stock rises on orders for Kakadu anti-aging serum
• NovaBay Pharma receives non-compliance letter from NYSE
• NovaBay Pharma enters into agreements for private placement and warrant reprice transactions to raise up to $5.3M
• NovaBay GAAP EPS of -$0.04 in-line, revenue of $3.04M misses by $0.47M
• NovaBay Q2 2022 Earnings Preview